Business
Viemed Healthcare Announces First Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has ...
About this update from Viemed Healthcare, Inc.
[{"type":"text","content":"LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026.","length":407,"tagName":"p"},{"type":"text","content":"Operational highlights (all dollar amounts are USD):","length":52,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.","length":196,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":196,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to Viemed for the quarter ended March 31, 2026 totaled $2.6 million, or $0.06 per diluted share.","length":120,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":120,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Adjusted EBITDA for the quarter ended March 31, 2026 totaled $14.3 million, a 12% increase as compared to the quarter ended March 31, 2025. The prior year period benefited from a $2.7 million non-recurring gain on disposal of property and equipment related to the ventilator return program, which concluded during 2025.","length":319,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":319,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net cash provided by operating activities totaled $8.1 million for the quarter and $57.1 million for the trailing twelve months ended March 31, 2026. Free cash flow totaled $2.6 million for the quarter and $36.3 million for the trailing twelve months ended March 31, 2026.","length":272,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":272,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"During the first quarter of 2026, the Company repurchased and cancelled 150,000 common shares under its share repurchase program at a cost of $1.4 million (excluding taxes), representing an average buyback price of $9.29 per share.","length"...